Search research articles
Contact Us
Filters
Showing results (71-80 of 939) with videos related to
Page
of 94
Sort By:
The Journal of Family Planning and Reproductive Health Care
|
June 30, 2004
'Taking the strain' from chlamydia screening
Jenny Hopwood, Harry Mallinson, Toni Gleave
Current Opinion in Urology
|
August 12, 2005
Antisense oligonucleotide therapy in the management of bladder cancer
Alan So, Palma Rocchi, Martin Gleave
Public Health
|
June 10, 2025
A jab is not a vaccine; it's a 'shot'
Zsófia Demjén, Elena Semino, Richard Gleave
Annals of the Royal College of Surgeons of England
|
September 1, 1992
Carcinoma of the major salivary glands
E N Gleave, N K Gupta
Current Drug Targets
|
March 20, 2003
Antisense targets to enhance hormone and cytotoxic therapies in advanced prostate cancer
Martin Gleave, Colleen Nelson, Kim Chi
Translational Andrology and Urology
|
January 28, 2016
Novel non-AR therapeutic targets in castrate resistant prostate cancer
Paul J Toren, Martin E Gleave
Urologic Oncology
|
December 30, 2008
The continued debate: intermittent vs. continuous hormonal ablation for metastatic prostate cancer
Martin Gleave, Laurence Klotz, Samir S Taneja
International Journal of Sport Nutrition and Exercise Metabolism
|
June 14, 2012
Effects of caffeine, sodium bicarbonate, and their combined ingestion on high-intensity cycling performance
Andrew E Kilding, Claire Overton, Jonathan Gleave
Cancer Research
|
June 13, 2000
Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models
H Miyake, M Pollak, M E Gleave
Medical and Veterinary Entomology
|
November 9, 2021
The effects of temephos, permethrin and malathion selection on the fitness and fecundity of Aedes aegypti
K Gleave, F Mechan, L J Reimer
Page
of 94
Search research articles
Search
Showing results (71-80 of 939) with videos related to
Sort By:
Page
of 94
The Journal of Family Planning and Reproductive Health Care
|
June 30, 2004
'Taking the strain' from chlamydia screening
Jenny Hopwood, Harry Mallinson, Toni Gleave
Current Opinion in Urology
|
August 12, 2005
Antisense oligonucleotide therapy in the management of bladder cancer
Alan So, Palma Rocchi, Martin Gleave
Public Health
|
June 10, 2025
A jab is not a vaccine; it's a 'shot'
Zsófia Demjén, Elena Semino, Richard Gleave
Annals of the Royal College of Surgeons of England
|
September 1, 1992
Carcinoma of the major salivary glands
E N Gleave, N K Gupta
Current Drug Targets
|
March 20, 2003
Antisense targets to enhance hormone and cytotoxic therapies in advanced prostate cancer
Martin Gleave, Colleen Nelson, Kim Chi
Translational Andrology and Urology
|
January 28, 2016
Novel non-AR therapeutic targets in castrate resistant prostate cancer
Paul J Toren, Martin E Gleave
Urologic Oncology
|
December 30, 2008
The continued debate: intermittent vs. continuous hormonal ablation for metastatic prostate cancer
Martin Gleave, Laurence Klotz, Samir S Taneja
International Journal of Sport Nutrition and Exercise Metabolism
|
June 14, 2012
Effects of caffeine, sodium bicarbonate, and their combined ingestion on high-intensity cycling performance
Andrew E Kilding, Claire Overton, Jonathan Gleave
Cancer Research
|
June 13, 2000
Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models
H Miyake, M Pollak, M E Gleave
Medical and Veterinary Entomology
|
November 9, 2021
The effects of temephos, permethrin and malathion selection on the fitness and fecundity of Aedes aegypti
K Gleave, F Mechan, L J Reimer
Page
of 94